Business Context and Reporting Period
This Form 8-K Current Report is filed by cbdMD, Inc. (NYSE American: YCBD) with a report date of December 5, 2025. The filing addresses the Company's regulatory status regarding its listing on the NYSE American LLC.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and exchange compliance status.
Material Changes
- Regulatory Compliance: On December 5, 2025, the Company received confirmation from NYSE Regulation that it has regained compliance with all continued listing standards.
- Deficiency Resolution: The Company resolved previously identified deficiencies under Sections 1003(a)(i) and (ii) of the NYSE American Company Guide, which were originally flagged in letters dated June 5, 2024, and December 31, 2024.
- Listing Status: The "below compliance" (.BC) indicator will be removed from the Company's stock, and it will be taken off the Exchange's list of noncompliant issuers.
Outlook, Risks, and Management Commentary
Management announced via press release (Exhibit 99.1) on December 8, 2025, that the Company has successfully regained compliance. Going forward, the Company will remain subject to NYSE Regulation's normal continued listing monitoring. No specific financial guidance, new risks, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the removal of the ".BC" (below compliance) indicator on the NYSE American website.
- Review the press release dated December 8, 2025 (Exhibit 99.1) for details on the specific actions taken to resolve the listing deficiencies.
- Confirm the Company's continued adherence to NYSE American listing standards in future periodic reports.